Evidence map›Paper›PMID 36621399›Full record

ArticleBulletin du cancer2023

[Experiences of patients with cancer during the first COVID-19 lockdown: What was the impact on the patients' healthcare pathway, mental condition, and access to supportive care in cancer?]

Carole Lefebvre, Patrick Heitzmann, Sylvie Pelletier, Thierry Lecomte, Abadallah Maakaroun

Abstract readEnglish Abstract
In one paragraph

Article in Bulletin du cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Carole LefebvreRéseau OncoCentre, dispositif spécifique régional du cancer (DSRC), 2, boulevard Tonnellé, 37044 Tours cedex 9, France. Electronic address: c.lefebvre@chu-tours.fr.
Patrick HeitzmannRéseau OncoCentre, dispositif spécifique régional du cancer (DSRC), 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
Sylvie PelletierRéseau OncoCentre, dispositif spécifique régional du cancer (DSRC), 2, boulevard Tonnellé, 37044 Tours cedex 9, France.
Thierry LecomteRéseau OncoCentre, dispositif spécifique régional du cancer (DSRC), 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Université de Tours, faculté de médecine, 10, boulevard Tonnellé, 37032 Tours cedex 1, France.
Abadallah MaakarounRéseau OncoCentre, dispositif spécifique régional du cancer (DSRC), 2, boulevard Tonnellé, 37044 Tours cedex 9, France; Centre hospitalier Jacques Coeur, 145, avenue François-Mitterrand, 18020 Bourges cedex, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic disrupted the organisation of the healthcare system. Very little data is available regarding the impact of the COVID-19 pandemic on patients' perceptions of their healthcare pathway. The objective of this survey was to evaluate cancer patients' perceptions of the impact of the first COVID-19 lockdown on continuity of care, their mental condition, as well as their access to Supportive Care in Cancer (SCC).

methodsBetween June 2nd and 30th, 2020, an anonymous questionnaire was sent out to the patients who visited 17 healthcare establishments in the Centre-Val de Loire region.

resultsOur survey questioned 861 patients, amongst which 839 were selected. The population was predominantly female (58%). Breast cancer was the most represented (27%). Approximately three patients out of four considered that their care was maintained during the lockdown. In total, 348 patients (44%) reported an altered mental status. Approximately 1/4th of patients benefited from SCC. More than half of the patients felt that SCC was not relevant to their situation, although 40% of these patients expressed mental issues.

conclusionOur survey highlighted a negative impact on patients' mental condition and a low use of SCC in spite of existing needs. This demonstrates the necessity of evaluating the patients' needs and offering adequate SCC at various stages of the healthcare pathway, as well as the need for a clearly identifiable offer for the healthcare professionals and the patients.

Indexed as

Breast NeoplasmsCOVID-19Communicable Disease ControlDelivery of Health CareFemaleHumansMalePandemicsCancerCOVID-19ExperienceExpériencePatientsSoins oncologiques de supportSupportive care in cancer

Identifiers

PMID36621399
PMCPMC9701632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.